UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in HIMS — Hims & Hers Health, Inc.
CIK 861177
NEW YORK, NY
Position in HIMS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$9,207,616
-$5,191,687 QoQ
Shares Held
443,527
+0.0% QoQ
Ownership
0.192%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 45.67839161990138.ToString("F0")%
Shared 0.ToString("F0")%
None 54.32160838009862.ToString("F0")%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $926,551,772 across 34 Drug Manufacturers - Specialty & Generic names. HIMS ranks #8 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,398,351 | $519,929,066 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
207,309 | $122,930,085 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
571,719 | $75,318,257 | |
| 4 | VTRS |
Viatris Inc
|
3,964,630 | $53,562,146 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
486,498 | $36,900,870 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,526,922 | $36,539,240 | |
| 7 | ALKS |
Alkermes plc.
|
403,153 | $14,255,486 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
This page
|
443,527 | $9,207,616 |
All Filings in HIMS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,207,616 | 443,527 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $14,399,303 | 443,465 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $25,396,658 | 447,755 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $35,671,610 | 715,579 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12,372,552 | 418,699 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $8,224,968 | 340,156 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,764,533 | 258,661 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,793,255 | 286,937 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,713,034 | 175,374 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,565,961 | 175,951 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,110,435 | 176,540 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,727,529 | 183,780 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,823,096 | 183,780 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,019,694 | 159,079 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $591,466 | 105,998 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $612,028 | 135,106 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $587,951 | 110,310 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $722,529 | 110,310 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $402,785 | 53,420 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $536,452 | 49,261 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||